Teknolojia hizi Tatu za Kugundua Afya ya Vyoo Zitajaribiwa Kitabibu Nchini Marekani, Israel na Japan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Juni. The technology gains life-saving medical insights by analysing human excrement. Kampuni imewasilisha msururu wa hataza tatu zinazofunika vipengele vya kihisi cha choo cha matibabu.

Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Ulaya, Japan na Uchina.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Teknolojia ya OutSense inaweza kutambua chanzo cha damu kwenye njia ya utumbo.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Kulingana na Mkurugenzi Mtendaji wa OutSense Yfat Scialom, who predicts that “na mlipuko wa dawa za kidijitali, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, ugonjwa wa matumbo ya uchochezi na maambukizi ya njia ya mkojo.
Its solution consists of a multispectral optical sensor, a light source and an autonomous screening device that includes a WiFi connection. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Information obtained from sampled blood, combined with additional analysis of the time from bleeding to excretion, provides details of the bleeding pathology. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense announced that CommuniCare, a large healthcare company with more than 90 healthcare facilities in the US, itaanza majaribio ya teknolojia yake mwaka huu. Mbali na majaribio haya, OutSense also plans to conduct clinical trials in Israel and Japan.

Tembelea habari zaidi kwa Habari za Viga.cc
Muuzaji wa Kiwanda cha Tap iVIGA